These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 657716)

  • 1. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
    Drayer DE; Restivo K; Reidenberg MM
    J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction.
    Halkin H; Vered Z; Millman P; Rabinowitz B; Neufeld HN
    Isr J Med Sci; 1979 Jul; 15(7):583-7. PubMed ID: 478822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors effecting quinidine concentration in blood and restoration of sinus rhythm in cardiac fibrillation].
    Ivanenko NA
    Vrach Delo; 1969 Aug; 8():5-8. PubMed ID: 5382490
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinidine therapy in hospitalized patients with ventricular arrhythmias.
    Carliner NH; Crouthamel WG; Fisher ML; Mugmon MA; Vassar DL; Narang PK; Plotnick GD
    Am Heart J; 1979 Dec; 98(6):708-15. PubMed ID: 495420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay.
    Carliner NH; Fisher ML; Crouthamel WG; Narang PK; Plotnick GD
    Am Heart J; 1980 Oct; 100(4):483-9. PubMed ID: 7415936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA; Blair IA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of quinidine short and long-acting in control of arrhythmias.
    Coodley E; Pugash N; Toppo F
    Angiology; 1984 Sep; 35(9):581-90. PubMed ID: 6486521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of quinidine metabolites to electrophysiologic responses in human subjects.
    Kavanagh KM; Wyse DG; Mitchell LB; Gilhooly T; Gillis AM; Duff HJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):352-8. PubMed ID: 2776394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An experimental model for the rational treatment of arrhythmias: a clinical study with quinidine].
    Pelosi G; Duca G; Bareggi SR; Pirola R; Hadëri B
    G Ital Cardiol; 1993 Aug; 23(8):777-86. PubMed ID: 8119501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
    Russo J; Russo ME; Smith RA; Pershing LK
    J Clin Pharmacol; 1982; 22(5-6):264-70. PubMed ID: 7107973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias.
    Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.